DD

Diptimayee Das

Active Director Director DIN 07644936
DIN 07644936 First appointment Dec 2016 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Diptimayee Das

Data last updated:

Diptimayee Das is a Director at Rezyrc Life Science Private Limited (since 2018) and Director at Cryzer Formulation Private Limited (since 2016). The companies operate in Healthcare and Pharma.

DIN 07644936
Primary Designation Director
Industry Healthcare
First Appointment 05 Dec 2016
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rezyrc Life Science Private Limited U74999OR2018PTC029043
Director18 Jun 20182018Active
Cryzer Formulation Private Limited U24299OR2016PTC026093
Director05 Dec 20162016Active

Board colleagues of Diptimayee Das

Directorship timeline

Open interactive timeline →
Cryzer Formulation Private Limited
Rezyrc Life Science Private Limited
Premium access

Shareholding and investment profile for Diptimayee Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Diptimayee Das

Diptimayee Das currently holds 2 directorships: Rezyrc Life Science Private Limited (Director, since 18 Jun 2018); Cryzer Formulation Private Limited (Director, since 05 Dec 2016).

Diptimayee Das was first appointed on 05 Dec 2016 as Director at Cryzer Formulation Private Limited. The most recent appointment on record is 18 Jun 2018 at Rezyrc Life Science Private Limited.

The current boards of Diptimayee Das's companies include Shasikanta Das (Rezyrc Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available